metastatic castration-resistant prostate cancer(English)

• remains a terminal diagnosis with an aggressive disease course despite currently approved therapeutics. The recent successful development of poly ADP-ribose polymerase (PARP) inhibitors for these patients and mutations in DNA damage repair genes has added to the treatment armamentarium and improved personalized treatments for prostate cancer
• PARP, PSMA, CRPC, nmCRPC, CTC, PSA, AR-V7, PCa
• Prostate, Oncology
• https://doi.org…045-020-00978-z
• https://doi.org…uro.2017.07.024
• https://doi.org…90/life11070664